TY - JOUR
T1 - Cripto-1
T2 - An extracellular protein - Connecting the sequestered biological dots
AU - Klauzinska, Malgorzata
AU - Bertolette, Daniel
AU - Tippireddy, Sudhamsh
AU - Strizzi, Luigi
AU - Gray, Peter C.
AU - Gonzales, Monica
AU - Duroux, Meg
AU - Ruvo, Menotti
AU - Wechselberger, Christian
AU - Castro, Nadia P.
AU - Rangel, Maria Cristina
AU - Focà, Annalia
AU - Sandomenico, Annamaria
AU - Hendrix, Mary J.C.
AU - Salomon, David
AU - Cuttitta, Frank
N1 - Publisher Copyright:
© 2015 © 2015 Taylor & Francis Group, LLC.
PY - 2015/9/3
Y1 - 2015/9/3
N2 - Cripto-1 (CR-1) is a multifunctional embryonic protein that is re-expressed during inflammation, wound repair, and malignant transformation. CR-1 can function either as a tethered co-receptor or shed as a free ligand underpinning its flexible role in cell physiology. CR-1 has been shown to mediate cell growth, migration, invasion, and induce epithelial to mesenchymal transition (EMT). The main signaling pathways mediating CR-1 effects include Nodal-dependent (Smad2/3) and Nodal-independent (Src/p44/42/Akt) signaling transduction pathways. In addition, there are several naturally occurring binding partner proteins (BPPs) for CR-1 that can either agonize or antagonize its bioactivity. We will review the collective role of CR-1 as an extracellular protein, discuss caveats to consider in developing a quantitation assay, define possible mechanistic avenues applicable for drug discovery, and report on our experimental approaches to overcome these problematic issues.
AB - Cripto-1 (CR-1) is a multifunctional embryonic protein that is re-expressed during inflammation, wound repair, and malignant transformation. CR-1 can function either as a tethered co-receptor or shed as a free ligand underpinning its flexible role in cell physiology. CR-1 has been shown to mediate cell growth, migration, invasion, and induce epithelial to mesenchymal transition (EMT). The main signaling pathways mediating CR-1 effects include Nodal-dependent (Smad2/3) and Nodal-independent (Src/p44/42/Akt) signaling transduction pathways. In addition, there are several naturally occurring binding partner proteins (BPPs) for CR-1 that can either agonize or antagonize its bioactivity. We will review the collective role of CR-1 as an extracellular protein, discuss caveats to consider in developing a quantitation assay, define possible mechanistic avenues applicable for drug discovery, and report on our experimental approaches to overcome these problematic issues.
KW - Autoantibodies
KW - Cripto-1
KW - Cripto-1 detection
KW - drug discovery
KW - inflammation
UR - http://www.scopus.com/inward/record.url?scp=84943362321&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943362321&partnerID=8YFLogxK
U2 - 10.3109/03008207.2015.1077239
DO - 10.3109/03008207.2015.1077239
M3 - Article
C2 - 26327334
AN - SCOPUS:84943362321
SN - 0300-8207
VL - 56
SP - 364
EP - 380
JO - Connective tissue research
JF - Connective tissue research
IS - 5
ER -